U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 8 of 8 results

Status:
US Approved Rx (2018)
First approved in 1959

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Methazolamide is topical carbonic anhydrase inhibitor. Methazolamide is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. Metha...
mixture
Status:
Possibly Marketed Outside US
First approved in 2013

Class:
MIXTURE

Status:
Investigational

Class:
PROTEIN

Status:
Investigational

Class:
PROTEIN

Status:
Possibly Marketed Outside US
First approved in 2020

Class:
PROTEIN